The Food and Drug Administration inspected White Plains Hospital Center Blood Bank in White Plains on March 13 for blood and blood products, according to data posted on the FDA’s website.
Reports from the inspection concluded the facility did not require changes to its operational management practices.
The FDA regularly evaluates facilities nationwide to verify employee practices and product compliance with federal regulations that safeguard public health. Outcomes from these inspections are made public.
As described on its website, the FDA is the agency charged with overseeing the production and distribution of human and animal drugs, biologics, medical supplies, and tobacco products to ensure safety and quality.
Information for this report was sourced from the U.S. Food and Drug Administration. The source data is available here.
